Evidence map›Paper›PMID 27492854›Full record

ArticleCancer gene therapy2016

Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.

C Li, Q Li, Y Cai, Y He, X Lan, W Wang, J Liu, S Wang, G Zhu, J Fan and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cancer gene therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Biomarker Potential of Vimentin in Oral Cancers.Life (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

C LiDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
Q LiSouthwest Medical College, Luzhou, China.
Y CaiDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
Y HeSouthwest Medical College, Luzhou, China.
X LanThe Fifth People's Hospital of Chengdu, Chengdu, China.
W WangDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
J LiuDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
S WangDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
G ZhuDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
J FanDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
Y ZhouDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
R SunDepartment of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu, China.
Sichuan Cancer Hospital · CNSouthwest Medical University · CNChengdu Fifth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is the most common cancer of the head and neck and is associated with a high rate of lymph node metastasis. The initial step in the metastasis and transition of tumors is epithelial-mesenchymal transition (EMT)-induced angiogenesis, which can be mediated by angiopoietin 2 (ANG2), a key regulatory factor in angiogenesis. In the present study, immunohistochemistry and real-time quantitative reverse transcriptase (qRT-PCR) were used to measure the expression of ANG2 in OSCC tissues. Plasmids encoding ANG2 mRNA were used for increased ANG2 expression in the OSCC cell line TCA8113. The short interfering RNA (siRNA)-targeting ANG2 mRNA sequences were used to inhibit ANG2 expression in TCA8113 cells. Subsequently, transwell assays were performed to examine the effects of ANG2 on TCA8113 cell migration and invasion. Furthermore, in vivo assays were performed to assess the effect of ANG2 on tumor growth. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assays and immunohistochemistry were used to examine cell apoptosis and angiogenesis in tumor tissues, respectively. Finally, western blot analysis was performed to evaluate tumor formation-related proteins in OSCC tissues. We found that protein expression of ANG2 was remarkably upregulated in OSCC tissues. Overexpression of ANG2 increased the migration and invasion of TCA8113 cells by regulating EMT. Further investigations showed that overexpression of ANG2 increased tumor growth in nude mice, and angiogenesis of OSCC tissues increased in the presence of ANG2 overexpression. Overexpression of ANG2 also reduced cell apoptosis in tumor tissue cells. Finally, we found that overexpression of ANG2 resulted in changes in the expression of tumor formation-related proteins including vimentin, E-cadherin, Bim, PUMA, Bcl-2, Bax, Cyclin D1, PCNA and CD31. Our findings show that ANG2 has an important role in the migration and invasion of OSCC. More importantly, further investigations suggested that overexpression of ANG2 might increase OSCC metastasis by promoting angiogenesis in nude mice. This stimulatory effect could be achieved by inducing abnormal EMT and by reducing apoptosis and increasing proliferation of cells.

Indexed as

Gene ExpressionAngiopoietin-2AnimalsCarcinoma, Squamous CellCell CycleCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalEpithelial-Mesenchymal TransitionHeterograftsHumansImmunohistochemistryMiceMouth NeoplasmsNeovascularization, PathologicAngiopoietin-2

Identifiers

PMID27492854
PMCPMC5033983
OpenAlexW2499794199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.